Clinton transition
Executive Summary
National Institutes of Health Associate Director for Science and Policy Jay Moskowitz will be the contact person responsible for familiarizing the incoming Clinton Administration with NIH. Moskowitz, who has been tapped as a deputy director by NIH Director Bernadine Healy, MD, and his staff will put together a paper summarizing NIH's mission, a description of major policy issues and programs, including high-visibility initiatives such as the NIH strategic plan, as well as short biographies. The NIH briefing document will be incorporated into a larger Public Health Service briefing statement, to be transmitted to HHS Secretary Sullivan during the first week of December. Other PHS agency representatives preparing briefing documents are the Centers for Disease Control and Prevention's Martha Catz and the Agency for Health Care Policy and Research's Risa Lavizzo.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth